Report Detail

Medical Devices & Consumables Global Nucleic Acid Amplification Detection and Diagnostics Market Growth (Status and Outlook) 2021-2026

  • RnM4355464
  • |
  • 17 November, 2021
  • |
  • Global
  • |
  • 123 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Devices & Consumables

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Size 2016-2026
    • 2.1.2 Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 Nucleic Acid Amplification Detection and Diagnostics Segment by Type
    • 2.2.1 Polymerase Chain Reaction (PCR)
    • 2.2.2 Polymerase Chain Reaction (PCR)
    • 2.2.3 Isothermal Amplification Technology
    • 2.2.4 Direct Nucleic Acid Detection
    • 2.2.5 CRISPR-Cas9
  • 2.3 Nucleic Acid Amplification Detection and Diagnostics Market Size by Type
    • 2.3.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Type
    • 2.3.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2016-2021)
  • 2.4 Nucleic Acid Amplification Detection and Diagnostics Segment by Application
    • 2.4.1 Hospital and Clinics
    • 2.4.2 Diagnostic Centers
    • 2.4.3 Research Institutes
    • 2.4.4 Others
  • 2.5 Nucleic Acid Amplification Detection and Diagnostics Market Size by Application
    • 2.5.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Application
    • 2.5.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2016-2021)

3 Nucleic Acid Amplification Detection and Diagnostics Market Size by Players

  • 3.1 Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Players
    • 3.1.1 Global Nucleic Acid Amplification Detection and Diagnostics Revenue by Players (2019-2021E)
    • 3.1.2 Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Players (2019-2021E)
  • 3.2 Global Nucleic Acid Amplification Detection and Diagnostics Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Nucleic Acid Amplification Detection and Diagnostics by Regions

  • 4.1 Nucleic Acid Amplification Detection and Diagnostics Market Size by Regions (2016-2021)
  • 4.2 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2016-2021)
  • 4.3 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2016-2021)
  • 4.4 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2016-2021)
  • 5.2 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2016-2021)
  • 5.3 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2016-2021)
  • 6.2 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2016-2021)
  • 6.3 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Nucleic Acid Amplification Detection and Diagnostics by Country (2016-2021)
  • 7.2 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2016-2021)
  • 7.3 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics by Region (2016-2021)
  • 8.2 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global Nucleic Acid Amplification Detection and Diagnostics Market Forecast

  • 10.1 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Regions (2021-2026)
    • 10.1.1 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Regions (2021-2026)
    • 10.1.2 Americas Nucleic Acid Amplification Detection and Diagnostics Forecast
    • 10.1.3 APAC Nucleic Acid Amplification Detection and Diagnostics Forecast
    • 10.1.4 Europe Nucleic Acid Amplification Detection and Diagnostics Forecast
    • 10.1.5 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Forecast
  • 10.2 Americas Nucleic Acid Amplification Detection and Diagnostics Forecast by Countries (2021-2026)
    • 10.2.1 United States Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.2.2 Canada Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.2.3 Mexico Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.2.4 Brazil Nucleic Acid Amplification Detection and Diagnostics Market Forecast
  • 10.3 APAC Nucleic Acid Amplification Detection and Diagnostics Forecast by Region (2021-2026)
    • 10.3.1 China Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.3.2 Japan Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.3.3 Korea Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.3.4 Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.3.5 India Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.3.6 Australia Nucleic Acid Amplification Detection and Diagnostics Market Forecast
  • 10.4 Europe Nucleic Acid Amplification Detection and Diagnostics Forecast by Country (2021-2026)
    • 10.4.1 Germany Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.4.2 France Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.4.3 UK Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.4.4 Italy Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.4.5 Russia Nucleic Acid Amplification Detection and Diagnostics Market Forecast
  • 10.5 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Forecast by Region (2021-2026)
    • 10.5.1 Egypt Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.5.2 South Africa Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.5.3 Israel Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.5.4 Turkey Nucleic Acid Amplification Detection and Diagnostics Market Forecast
    • 10.5.5 GCC Countries Nucleic Acid Amplification Detection and Diagnostics Market Forecast
  • 10.6 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Type (2021-2026)
  • 10.7 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 BD
    • 11.1.1 BD Company Information
    • 11.1.2 BD Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.1.3 BD Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 BD Main Business Overview
    • 11.1.5 BD Latest Developments
  • 11.2 BioMerieux SA
    • 11.2.1 BioMerieux SA Company Information
    • 11.2.2 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.2.3 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 BioMerieux SA Main Business Overview
    • 11.2.5 BioMerieux SA Latest Developments
  • 11.3 BIO-RAD LABORATORIES INC.
    • 11.3.1 BIO-RAD LABORATORIES INC. Company Information
    • 11.3.2 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.3.3 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 BIO-RAD LABORATORIES INC. Main Business Overview
    • 11.3.5 BIO-RAD LABORATORIES INC. Latest Developments
  • 11.4 THERMO FISHER SCIENTIFIC INC.
    • 11.4.1 THERMO FISHER SCIENTIFIC INC. Company Information
    • 11.4.2 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.4.3 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 THERMO FISHER SCIENTIFIC INC. Main Business Overview
    • 11.4.5 THERMO FISHER SCIENTIFIC INC. Latest Developments
  • 11.5 Illumina, Inc.
    • 11.5.1 Illumina, Inc. Company Information
    • 11.5.2 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.5.3 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Illumina, Inc. Main Business Overview
    • 11.5.5 Illumina, Inc. Latest Developments
  • 11.6 Danaher
    • 11.6.1 Danaher Company Information
    • 11.6.2 Danaher Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.6.3 Danaher Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Danaher Main Business Overview
    • 11.6.5 Danaher Latest Developments
  • 11.7 QIAGEN
    • 11.7.1 QIAGEN Company Information
    • 11.7.2 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.7.3 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 QIAGEN Main Business Overview
    • 11.7.5 QIAGEN Latest Developments
  • 11.8 Abbott
    • 11.8.1 Abbott Company Information
    • 11.8.2 Abbott Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.8.3 Abbott Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 Abbott Main Business Overview
    • 11.8.5 Abbott Latest Developments
  • 11.9 Meridian Bioscience, Inc.
    • 11.9.1 Meridian Bioscience, Inc. Company Information
    • 11.9.2 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.9.3 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 Meridian Bioscience, Inc. Main Business Overview
    • 11.9.5 Meridian Bioscience, Inc. Latest Developments
  • 11.10 F. Hoffmann-La Roche Ltd.
    • 11.10.1 F. Hoffmann-La Roche Ltd. Company Information
    • 11.10.2 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.10.3 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 F. Hoffmann-La Roche Ltd. Main Business Overview
    • 11.10.5 F. Hoffmann-La Roche Ltd. Latest Developments

11. PreAnalytiX

  • 11.11.1 PreAnalytiX Company Information
  • 11.11.2 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Product Offered
  • 11.11.3 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
  • 11.11.4 PreAnalytiX Main Business Overview
  • 11.11.5 PreAnalytiX Latest Developments
  • 11.12 Eiken Chemical
    • 11.12.1 Eiken Chemical Company Information
    • 11.12.2 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.12.3 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.12.4 Eiken Chemical Main Business Overview
    • 11.12.5 Eiken Chemical Latest Developments
  • 11.13 Lucigen
    • 11.13.1 Lucigen Company Information
    • 11.13.2 Lucigen Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.13.3 Lucigen Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.13.4 Lucigen Main Business Overview
    • 11.13.5 Lucigen Latest Developments
  • 11.14 OptiGene
    • 11.14.1 OptiGene Company Information
    • 11.14.2 OptiGene Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.14.3 OptiGene Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.14.4 OptiGene Main Business Overview
    • 11.14.5 OptiGene Latest Developments
  • 11.15 NEB
    • 11.15.1 NEB Company Information
    • 11.15.2 NEB Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.15.3 NEB Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.15.4 NEB Main Business Overview
    • 11.15.5 NEB Latest Developments
  • 11.16 Quidel Corporation
    • 11.16.1 Quidel Corporation Company Information
    • 11.16.2 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.16.3 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.16.4 Quidel Corporation Main Business Overview
    • 11.16.5 Quidel Corporation Latest Developments
  • 11.17 Promega
    • 11.17.1 Promega Company Information
    • 11.17.2 Promega Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.17.3 Promega Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.17.4 Promega Main Business Overview
    • 11.17.5 Promega Latest Developments
  • 11.18 Hologic
    • 11.18.1 Hologic Company Information
    • 11.18.2 Hologic Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.18.3 Hologic Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.18.4 Hologic Main Business Overview
    • 11.18.5 Hologic Latest Developments
  • 11.19 Ustar
    • 11.19.1 Ustar Company Information
    • 11.19.2 Ustar Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.19.3 Ustar Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.19.4 Ustar Main Business Overview
    • 11.19.5 Ustar Latest Developments
  • 11.20 Grifols
    • 11.20.1 Grifols Company Information
    • 11.20.2 Grifols Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.20.3 Grifols Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.20.4 Grifols Main Business Overview
    • 11.20.5 Grifols Latest Developments
  • 11.21 Nugen
    • 11.21.1 Nugen Company Information
    • 11.21.2 Nugen Nucleic Acid Amplification Detection and Diagnostics Product Offered
    • 11.21.3 Nugen Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
    • 11.21.4 Nugen Main Business Overview
    • 11.21.5 Nugen Latest Developments
  • 12 Research Findings and Conclusion

    According to this latest study, the 2021 growth of Nucleic Acid Amplification Detection and Diagnostics will have significant change from previous year. By the most conservative estimates of global Nucleic Acid Amplification Detection and Diagnostics market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Nucleic Acid Amplification Detection and Diagnostics market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

    This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Amplification Detection and Diagnostics market by product type, application, key players and key regions and countries.

    Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    Polymerase Chain Reaction (PCR)
    Next Generation Sequencing (NGS)
    Isothermal Amplification Technology
    Direct Nucleic Acid Detection
    CRISPR-Cas9

    Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    Hospital and Clinics
    Diagnostic Centers
    Research Institutes
    Others

    This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    BD
    BioMerieux SA
    BIO-RAD LABORATORIES INC.
    THERMO FISHER SCIENTIFIC INC.
    Illumina, Inc.
    Danaher
    QIAGEN
    Abbott
    Meridian Bioscience, Inc.
    F. Hoffmann-La Roche Ltd.
    PreAnalytiX
    Eiken Chemical
    Lucigen
    OptiGene
    NEB
    Quidel Corporation
    Promega
    Hologic
    Ustar
    Grifols
    Nugen


    Summary:
    Get latest Market Research Reports on Nucleic Acid Amplification Detection and Diagnostics . Industry analysis & Market Report on Nucleic Acid Amplification Detection and Diagnostics is a syndicated market report, published as Global Nucleic Acid Amplification Detection and Diagnostics Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of Nucleic Acid Amplification Detection and Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,646.00
    5,292.00
    3,108.00
    6,216.00
    397,460.00
    794,920.00
    264,355.00
    528,710.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report